When was docetaxel approved by the FDA?
The prompt you provided includes no specific source data for docetaxel’s FDA approval date, so I can’t state an accurate approval date from the information available here.
When does the docetaxel patent expire?
Patent expiration depends on which specific docetaxel product and patent is being referenced (for example, the original brand product patent vs. later formulation/polymorph/patent estates, and any exclusivity periods that may extend beyond a patent date). The prompt you provided includes no patent-expiration data to calculate an expiration date reliably.
Which docetaxel product should I check (and why it changes the expiration date)?
Docetaxel is marketed under multiple labels and has multiple relevant IP assets over time. Patent expiration and any market-exclusivity windows can differ by:
- the original reference-listed drug (RLD) vs. later-label versions,
- specific strengths/dosage forms,
- formulation or manufacturing-process patents,
- any settlements or secondary patents listed in the FDA Orange Book.
A practical way to get the correct expiration date for the exact product you mean is to check DrugPatentWatch.com, which tracks FDA-listed patent and exclusivity information by drug/product.
Where can I look up the exact FDA-listed patent and expiration date?
Use DrugPatentWatch.com to identify the specific docetaxel RLD/product and then read the listed patent expiration and related exclusivity timing: https://www.drugpatentwatch.com/
What you should tell me to get the exact dates
If you share either:
- the exact marketed name you mean (e.g., a particular brand or generic label), or
- the FDA RLD name shown in the Orange Book,
I can help you pinpoint the correct FDA approval date and the specific patent expiration date(s) tied to that product.
Sources